is dulaglutide a glp-1 Novel agonist wins AWARD for type 2 diabetes Therapeutic Effects of Glucagon-like Peptide-1

Still, this early study indicates GLP-1 medications therapeutic potential in ocular inflammatory disease

Danish pharmaceutical company Novo Nordisk started making Ozempic to help people with diabetes

The Phase 2 trial followed participants through 48 weeks of treatment but did not include an extended washout observation period comparable to longer post-trial data available for Semaglutide

Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus

The most common side effects of GLP-1s are: Nausea Diarrhea Constipation Vomiting Abdominal pain Headache In most cases, these side effects improve as your body adjusts to the medication

After receiving your first Semaglutide (GLP-1) injection, the medication begins working within hours by mimicking the natural GLP-1 hormone in your body